Ryan Mallory

Ryan Mallory

Ryan Mallory is the founder of the financial blog SharePlanner.com, where he provides traders with daily market plans, trading ideas and setups, along with a look at how he manages his own portfolio on a daily basis.

His articles have appeared on numerous financials blogs, and he has earned the reputation for being one of the most open and honest traders in his field.

On top writing for SharePlanner, he also manages his own hedge fund.

Ryan studied Political Science and Economics at the University of Central Florida and went on to attain his MBA as well.

Recent Articles

Go Long MCD, Short ADBE

McDonald's Corp. (NYSE: MCD) is a defensive stock to buy, while Adobe Systems Inc. (NASDAQ: ADBE) will make a good stock to short if the trendline breaks.

Your Signal to Cash Out

If the S&P 500 closes below its 20-day moving average, then you may want to close out your long positions.

Will the Shorts Cash In?

After being burned numerous times by not taking profits after significant market sell-offs, the bears could be all too willing to do so today.

Traders Should Exercise Caution on Open

A lot of volatility in overnight futures trading should be an alarm to traders to be very careful heading into the open.

Get Ready for the Next Leg Up

Yesterday's pullback was more about profit-taking than anything else, providing a good opportunity to start adding long positions.

More Risk Than Reward in This Market

The market is overextended and traders should wait for a better entry point.

Market Setting Up for a Short-term Pullback

Wait for the market to give back some gains before jumping into anything on the long side.

Brief Pullback Could Create Buying Opportunity

Traders should consider adding new long positions to their portfolios on any market weakness.

Breakout Signals Resumed Uptrend

The S&P 500 managed to close a point above the recent highs, allowing for it to break out of consolidation and resume the upward trend.

Go Long PCX, Short SLXP

Patriot Coal Corporation (NYSE: PCX) should soar while Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) stumbles.